Patent 12070459 was granted and assigned to Intra-Cellular Therapies on August, 2024 by the United States Patent and Trademark Office.
The present disclosure relates to pharmaceutical capsules comprising lumateperone, in free, or pharmaceutically acceptable salt form, optionally in combination with one or more additional therapeutic agents, processes for manufacture thereof and methods of use in the treatment or prophylaxis of disease.